Personal information

Websites & social links

Twitter

Activities

Collapse all

Employment (3)

Cleveland Clinic Foundation: Cleveland, OH, US

2022 to 2024 | Interventional fellow (Interventional Cardiology)
Employment
Source: Self-asserted source
Calvin Sheng

Cleveland Clinic Foundation: Cleveland, OH, US

2019 to 2022 | General cardiology fellow (Cardiovascular Medicine )
Employment
Source: Self-asserted source
Calvin Sheng

Johns Hopkins Hospital: Baltimore, Maryland, US

2016 to 2019 | Resident (Internal Medicine)
Employment
Source: Self-asserted source
Calvin Sheng

Education and qualifications (2)

Vanderbilt University School of Medicine: Nashville, TN, US

2011 to 2016 | MD
Education
Source: Self-asserted source
Calvin Sheng

Duke University: Durham, NC, US

2007 to 2011 | BS (Biology)
Education
Source: Self-asserted source
Calvin Sheng

Works (19)

Successful Transseptal Transcatheter Aortic Valve Replacement With Monitored Anesthesia Care and Standard Delivery System

Structural Heart
2025-02 | Journal article
DOI: 10.1016/j.shj.2024.100358
Contributors: Zade Akras; Nabil Sabbak; Calvin C. Sheng; James Yun; Samir R. Kapadia
Source: check_circle
Crossref

Images in Vascular Medicine: Valsalva purpura secondary to balloon occlusion of the cavoatrial junction during intervention for lead-induced SVC syndrome

Vascular Medicine
2023-10 | Journal article
DOI: 10.1177/1358863X231191902
Contributors: Calvin C Sheng; Bruce L Wilkoff; Sean P Lyden; Edward Soltesz; Scott J Cameron; Aravinda Nanjundappa
Source: check_circle
Crossref

Successful Endovascular Treatment of an Anastomotic Pseudoaneurysm in the Ascending Aorta

The American Journal of Cardiology
2023-09 | Journal article
DOI: 10.1016/j.amjcard.2023.05.060
Contributors: Calvin Chen Sheng; Adrian Santini; Frank H. Annie; Muhammad Rawala; Deepak L. Bhatt; Aravinda Nanjundappa
Source: check_circle
Crossref

Comparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery Disease Before Liver Transplantation.

Annals of transplantation
2021-12-22 | Journal article
DOI: 10.12659/aot.934163
PMID: 34934037
PMC: PMC8711211
Contributors: Calvin Sheng; Kleb C; Jain V; Sheth C; Wolski K; Kapadia S; Grimm R; Desai M; Krishnaswamy A; Kassis N et al.
Source: Self-asserted source
Calvin Sheng

Patients with varying courses of single coronary artery: case series.

European heart journal. Case reports
2021-09-03 | Journal article | Author
DOI: 10.1093/ehjcr/ytab314
PMID: 34661051
PMC: PMC8515176
Contributors: Calvin Sheng; Joanna Ghobrial, MD, MSc; leslie cho
Source: Self-asserted source
Calvin Sheng
grade
Preferred source (of 2)‎

SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications.

Current cardiology reports
2021-08-03 | Journal article
DOI: 10.1007/s11886-021-01551-x
PMID: 34342728
PMC: PMC8330199
Contributors: Calvin Sheng; Abou Hassan OK; Sheng CC; Wang TKM; Paul Cremer
Source: Self-asserted source
Calvin Sheng

Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation.

European heart journal open
2021-07-29 | Journal article
DOI: 10.1093/ehjopen/oeab002
PMID: 35923169
PMC: PMC9242054
Contributors: Calvin Sheng; Paul Cremer; Sheng CC; Sahoo D; Dugar S; Prada RA; Wang TKM; Hassan OKA; Hernandez-Montfort J; Wolinsky DA et al.
Source: Self-asserted source
Calvin Sheng

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial.

The Lancet. Rheumatology
2021-03-17 | Journal article
DOI: 10.1016/s2665-9913(21)00070-9
PMID: 33754144
PMC: PMC7969143
Contributors: Calvin Sheng; Cremer PC; Abbate A; Hudock K; McWilliams C; Mehta J; Chang SY; Sheng CC; Van Tassell B; Bonaventura A et al.
Source: Self-asserted source
Calvin Sheng

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).

Clinical cardiology
2020-08-24 | Journal article
DOI: 10.1002/clc.23451
PMID: 32830894
PMC: PMC7461303
Contributors: Calvin Sheng; Sheng CC; Sahoo D; Dugar S; Prada RA; Wang TKM; Abou Hassan OK; Brennan D; Culver DA; Rajendram P et al.
Source: Self-asserted source
Calvin Sheng

Force Generation via β-Cardiac Myosin, Titin, and α-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix Adhesions.

Developmental cell
2018-01-08 | Journal article
DOI: 10.1016/j.devcel.2017.12.012
PMID: 29316444
PMC: PMC6421364
Contributors: Calvin Sheng; Chopra A; Matthew L Kutys; Kehan Zhang; William Polacheck; Sheng CC; Luu RJ; Eyckmans J; Hinson JT; Seidman JG et al.
Source: Self-asserted source
Calvin Sheng

Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.

Cell reports
2017-06-01 | Journal article
DOI: 10.1016/j.celrep.2017.05.038
PMID: 28614725
Contributors: Calvin Sheng; Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; O'Sullivan J; Rowe G; Wakimoto H et al.
Source: Self-asserted source
Calvin Sheng

Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis.

Cell reports
2016-12-01 | Journal article
DOI: 10.1016/j.celrep.2016.11.066
PMID: 28009297
PMC: PMC5193246
Contributors: Calvin Sheng; Hinson JT; Chopra A; Lowe A; Sheng CC; Gupta RM; Kuppusamy R; John F. O'Sullivan; Rowe, GC; Wakimoto H et al.
Source: Self-asserted source
Calvin Sheng

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine.

JACC. Basic to translational science
2016-08-01 | Journal article
DOI: 10.1016/j.jacbts.2016.05.008
PMID: 28713868
PMC: PMC5508213
Contributors: Calvin Sheng; Sheng CC; Amiri-Kordestani L; Palmby T; Force T; Hong CC; Wu JC; Croce K; Kim G; Moslehi J
Source: Self-asserted source
Calvin Sheng

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

Science (New York, N.Y.)
2015-08-01 | Journal article
DOI: 10.1126/science.aaa5458
PMID: 26315439
PMC: PMC4618316
Contributors: Calvin Sheng; Hinson JT; Chopra A; Nafissi N; William Polacheck; Benson CC; Sandra Swist; Gorham J; Yang L; Sebastian Schäfer et al.
Source: Self-asserted source
Calvin Sheng

Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes.

Biomaterials
2015-07-14 | Journal article
DOI: 10.1016/j.biomaterials.2015.07.004
PMID: 26204225
PMC: PMC4550551
Contributors: Calvin Sheng; Chun YW; Daniel Balikov; Tromondae Feaster; Charles Williams; Sheng CC; Lee JB; Boire TC; Neely MD; Bellan LM et al.
Source: Self-asserted source
Calvin Sheng

Current stem cell delivery methods for myocardial repair.

BioMed research international
2012-12-27 | Journal article
DOI: 10.1155/2013/547902
PMID: 23509740
PMC: PMC3591183
Contributors: Calvin Sheng; Sheng CC; Zhou L; Hao J
Source: Self-asserted source
Calvin Sheng

Mixing of the old with the new: nanoparticle-mediated pioglitazone delivery to enhance therapeutic neovascularization.

Arteriosclerosis, thrombosis, and vascular biology
2012-10-01 | Journal article
DOI: 10.1161/atvbaha.112.300217
PMID: 22972937
PMC: PMC3672409
Contributors: Calvin Sheng; Sheng CC; Hong CC
Source: Self-asserted source
Calvin Sheng

Mapping of ionomic traits in Mimulus guttatus reveals Mo and Cd QTLs that colocalize with MOT1 homologues.

PloS one
2012-01-24 | Journal article
DOI: 10.1371/journal.pone.0030730
PMID: 22292026
PMC: PMC3265502
Contributors: Calvin Sheng; Lowry DB; Sheng CC; Zhu Z; Juenger TE; Lahner B; Salt DE; Willis JH
Source: Self-asserted source
Calvin Sheng

Five anthocyanin polymorphisms are associated with an R2R3-MYB cluster in Mimulus guttatus (Phrymaceae).

American journal of botany
2011-12-20 | Journal article
DOI: 10.3732/ajb.1100285
PMID: 22186184
Contributors: Calvin Sheng; Lowry DB; Sheng CC; Lasky JR; Willis JH
Source: Self-asserted source
Calvin Sheng
How many people are using ORCID?